Intelligence Platform

Patents

Browse 2,465 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 9080174

HBV treatment

Benitec Biopharma Limited · Granted Tue Jul 14 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 09 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9072732

Indication for use of niacin (nicotinic acid) for treatment and reversal of fatty liver di

The Regents of the University of California · Granted Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9066965

Purified limonin glucoside for prevention and treatment of chronic diseases

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9068007

Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial

The Board of Regents of the University of Texas System · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9068002

Treatment of multiple sclerosis and/or rheumatoid arthritis

Universität Regensburg · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9066943

Use of botulinum toxin therapy for treatment of urological neurological conditions

The Regents of the University of Colorado · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9066855

Controlled release auris sensory cell modulator compositions and methods for the treatment

The Regents of the University of California · Granted Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9061016

Aqueous solution comprising 3-quinuclidinones for the treatment hyperproliferative, autoim

APREA AB · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9060995

Treatment of circadian rhythm disorders

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 23 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9057104

Antipsychotic treatment based on DRD2 or ANKK1 SNP genotype

VANDA PHARMACEUTICALS INC. · Granted Tue Jun 16 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050299

Administration of growth factors for the treatment of CNS disorders

The Regents of the University of California · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050263

Pharmaceutical compositions for the treatment of Helicobacter pylori

RedHill Biopharma Ltd. · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9051271

Substituted pyridine derivatives useful in the treatment of cancer

UNITED ARAB EMIRATES UNIVERSITY · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9050343

Combination of pimavanserin and risperidone for the treatment of psychosis

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9044451

Use of delta tocopherol for the treatment of lysosomal storage disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jun 02 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034347

Drug delivery system and method for the treatment of neuro-degenerative disease

Arphios Corporation · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034923

Methods for the treatment of senile dementia of the alzheimer's type

Phenomenome Discoveries Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034881

Treatment for vitiligo

Rigel Pharmaceuticals, Inc. · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9034318

Chemically modified cystathionine beta-synthase enzyme for treatment of homocystinuria

The Regents of the University of Colorado, a Body Corporate · Granted Tue May 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 14 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9028842

Compositions and methods for treatment, research and therapeutic applications for malaria

Northwestern University · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9029413

Treatment of viral infections by modulation of host cell metabolic pathways

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9023356

Treatment method using EGFR antibodies and SRC inhibitors and related formulations

The Regents of the University of California · Granted Tue May 05 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 30 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9018371

Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositio

THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9018380

Heterocyclic modulators of HIF activity for treatment of disease

Boards of Regents, The University of Texas System · Granted Tue Apr 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

granted